BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34916564)

  • 1. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
    Guo J; Li X; Shen S; Wu X
    Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma.
    Liang T; Chen J; Xu G; Zhang Z; Xue J; Zeng H; Jiang J; Chen T; Qin Z; Li H; Ye Z; Nie Y; Liu C; Zhan X
    Sci Rep; 2021 Sep; 11(1):19315. PubMed ID: 34588497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
    Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
    Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
    Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
    Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma.
    Zhang K; Lu S; Jiang M; Zou X; Chen C; Lan Y; Zhao H; Ma R; Yan H
    Front Biosci (Landmark Ed); 2024 May; 29(5):193. PubMed ID: 38812298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
    He L; Yang H; Huang J
    BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immune-related eleven-RNA signature-drived risk score model for prognosis of osteosarcoma metastasis.
    Teng JS; Wang Y
    Sci Rep; 2024 Jun; 14(1):13401. PubMed ID: 38862526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of ubiquitin/ubiquitin-like-related genes along with immune cell infiltration and clinicopathological features in osteosarcoma.
    Wen J; Wan L; Chen W; Dong X
    J Orthop Surg Res; 2024 Jun; 19(1):356. PubMed ID: 38879525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma.
    Wang Q; Zhang W; Guo Y; Li Y; Fu K
    Aging (Albany NY); 2021 Nov; 13(21):24155-24170. PubMed ID: 34747719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning survival prediction using tumor lipid metabolism genes for osteosarcoma.
    Li S; Zheng Z; Wang B
    Sci Rep; 2024 Jun; 14(1):12934. PubMed ID: 38839983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
    Zhang Y; Liu K; Wang J
    Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.
    Chen J; Guo X; Zeng G; Liu J; Zhao B
    Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
    Li G; Lei J; Xu D; Yu W; Bai J; Wu G
    Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of two immune subtypes in osteosarcoma based on immune gene sets.
    Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z
    Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.